Tech Company Financing Transactions
SynDevRx Funding Round
SynDevRx closed a $9.1 million financing round on 9/16/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/16/2015
Transaction Type
Debt
Amount
$9,093,899
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
One Broadway 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit angiogenesis and prevent metastasis in early clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradley Carver
VP - Bus. Development
James Shanahan
Browse more venture capital transactions:
Prev: 9/16/2015: Coalfire Systems venture capital transaction
Next: 9/16/2015: Vestagen Protective Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs